Alexis N. LaCrue

656 total citations
14 papers, 281 citations indexed

About

Alexis N. LaCrue is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Alexis N. LaCrue has authored 14 papers receiving a total of 281 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Public Health, Environmental and Occupational Health, 5 papers in Molecular Biology and 3 papers in Computational Theory and Mathematics. Recurrent topics in Alexis N. LaCrue's work include Malaria Research and Control (12 papers), Mosquito-borne diseases and control (6 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (4 papers). Alexis N. LaCrue is often cited by papers focused on Malaria Research and Control (12 papers), Mosquito-borne diseases and control (6 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (4 papers). Alexis N. LaCrue collaborates with scholars based in United States, Switzerland and Australia. Alexis N. LaCrue's co-authors include Dennis E. Kyle, Katherine Kennedy, Roman Manetsch, Tina Mutka, Franka Teuscher, Norman C. Waters, Nanhua Chen, Qin Cheng, Michelle L. Gatton and Andrii Monastyrskyi and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Alexis N. LaCrue

14 papers receiving 272 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexis N. LaCrue United States 10 204 72 67 67 49 14 281
Benigno Crespo Spain 7 194 1.0× 51 0.7× 68 1.0× 100 1.5× 40 0.8× 9 276
Mariëtte van der Watt South Africa 11 162 0.8× 80 1.1× 81 1.2× 63 0.9× 42 0.9× 20 276
Félix Calderón Spain 11 156 0.8× 120 1.7× 112 1.7× 79 1.2× 41 0.8× 21 323
Alexandre S. Lawrenson United Kingdom 10 131 0.6× 128 1.8× 87 1.3× 67 1.0× 57 1.2× 11 338
Claribel Murillo-Solano United States 11 158 0.8× 74 1.0× 64 1.0× 38 0.6× 23 0.5× 13 287
Mohammed Al‐Helal United Kingdom 8 260 1.3× 120 1.7× 74 1.1× 70 1.0× 77 1.6× 8 399
Jeanne A. Geyer United States 11 161 0.8× 117 1.6× 128 1.9× 99 1.5× 74 1.5× 12 373
Thomas Antoine United Kingdom 6 170 0.8× 117 1.6× 38 0.6× 63 0.9× 50 1.0× 8 308
Mara Kreishman-Deitrick United States 11 177 0.9× 91 1.3× 89 1.3× 29 0.4× 29 0.6× 16 345
Suet C. Leung United Kingdom 8 130 0.6× 81 1.1× 104 1.6× 49 0.7× 50 1.0× 12 279

Countries citing papers authored by Alexis N. LaCrue

Since Specialization
Citations

This map shows the geographic impact of Alexis N. LaCrue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexis N. LaCrue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexis N. LaCrue more than expected).

Fields of papers citing papers by Alexis N. LaCrue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexis N. LaCrue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexis N. LaCrue. The network helps show where Alexis N. LaCrue may publish in the future.

Co-authorship network of co-authors of Alexis N. LaCrue

This figure shows the co-authorship network connecting the top 25 collaborators of Alexis N. LaCrue. A scholar is included among the top collaborators of Alexis N. LaCrue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexis N. LaCrue. Alexis N. LaCrue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Kerr, A., Mark Whiteside, Chad Huff, et al.. (2023). Dengue Outbreak Response during COVID-19 Pandemic, Key Largo, Florida, USA, 2020. Emerging infectious diseases. 29(8). 1643–1647. 10 indexed citations
2.
Monastyrskyi, Andrii, Alexis N. LaCrue, Steven P. Maher, et al.. (2021). Aminoalkoxycarbonyloxymethyl Ether Prodrugs with a pH-Triggered Release Mechanism: A Case Study Improving the Solubility, Bioavailability, and Efficacy of Antimalarial 4(1H)-Quinolones with Single Dose Cures. Journal of Medicinal Chemistry. 64(10). 6581–6595. 11 indexed citations
3.
Monastyrskyi, Andrii, Tina Mutka, Alexis N. LaCrue, et al.. (2017). Design and Synthesis of Orally Bioavailable Piperazine Substituted 4(1H)-Quinolones with Potent Antimalarial Activity: Structure–Activity and Structure–Property Relationship Studies. Journal of Medicinal Chemistry. 61(4). 1450–1473. 27 indexed citations
4.
Mutka, Tina, Alexis N. LaCrue, Jeremy N. Burrows, et al.. (2016). ICI 56,780 Optimization: Structure–Activity Relationship Studies of 7-(2-Phenoxyethoxy)-4(1H)-quinolones with Antimalarial Activity. Journal of Medicinal Chemistry. 59(14). 6943–6960. 20 indexed citations
5.
Cross, R. Matthew, Andrii Monastyrskyi, Alexis N. LaCrue, et al.. (2014). Orally Bioavailable 6-Chloro-7-methoxy-4(1H)-quinolones Efficacious against Multiple Stages of Plasmodium. Journal of Medicinal Chemistry. 57(21). 8860–8879. 33 indexed citations
6.
Chen, Nanhua, Alexis N. LaCrue, Franka Teuscher, et al.. (2014). Fatty Acid Synthesis and Pyruvate Metabolism Pathways Remain Active in Dihydroartemisinin-Induced Dormant Ring Stages of Plasmodium falciparum. Antimicrobial Agents and Chemotherapy. 58(8). 4773–4781. 57 indexed citations
7.
LaCrue, Alexis N., et al.. (2013). Expression profile of the Plasmodium falciparum intra-erythrocytic stage protein, PF3D7_1363700. Malaria Journal. 12(1). 66–66. 2 indexed citations
8.
Saénz, Fabián E., Alexis N. LaCrue, R. Matthew Cross, et al.. (2013). 4-(1 H )-Quinolones and 1,2,3,4-Tetrahydroacridin-9(10 H )-Ones Prevent the Transmission of Plasmodium falciparum to Anopheles freeborni. Antimicrobial Agents and Chemotherapy. 57(12). 6187–6195. 18 indexed citations
9.
LaCrue, Alexis N., et al.. (2012). PFE0565w, a Plasmodium falciparum Protein Expressed in Salivary Gland Sporozoites. American Journal of Tropical Medicine and Hygiene. 86(6). 943–954. 2 indexed citations
10.
LaCrue, Alexis N., et al.. (2012). Transcript and protein expression profile of PF11_0394, a Plasmodium falciparum protein expressed in salivary gland sporozoites. Malaria Journal. 11(1). 80–80. 1 indexed citations
11.
LaCrue, Alexis N., Fabián E. Saénz, R. Matthew Cross, et al.. (2012). 4(1H)-Quinolones with Liver Stage Activity against Plasmodium berghei. Antimicrobial Agents and Chemotherapy. 57(1). 417–424. 23 indexed citations
12.
LaCrue, Alexis N., et al.. (2011). Effects of Artesunate on Parasite Recrudescence and Dormancy in the Rodent Malaria Model Plasmodium vinckei. PLoS ONE. 6(10). e26689–e26689. 58 indexed citations
13.
LaCrue, Alexis N., Mayandi Sivaguru, Marika F. Walter, et al.. (2006). A ubiquitous Plasmodium protein displays a unique surface labeling pattern in sporozoites. Molecular and Biochemical Parasitology. 148(2). 199–209. 13 indexed citations
14.
LaCrue, Alexis N., Anthony A. James, & Brenda T. Beerntsen. (2005). THE NOVEL PLASMODIUM GALLINACEUM SPOROZOITE PROTEIN, PG93, IS PREFERENTIALLY EXPRESSED IN THE NUCLEUS OF OOCYST SPOROZOITES. American Journal of Tropical Medicine and Hygiene. 73(3). 634–643. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026